Home › Funds › Lazard › Lazard US Systematic Small Cap Equity ETF
Fund family: Lazard · Filed by Lazard Active ETF Trust (CIK 2051630) · SEC series S000094313
Ticker: SYZ (C000262801)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 3,185 with, 29 against, 0 abstentions (not counted as with management); 3 items carried no recommendation. Shareholder proposals: 10 FOR, 15 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as Lazard’s manager page (35,531 ballot items across 33 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Lazard | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 85.2% | 3,101 | 89.1% | 28,705 |
| Backed environmental and social shareholder proposals at US companies | n/a | 7 | 18.4% | 272 |
Each ballot item this fund voted is set against the votes of the other Lazard funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Lazard funds on 1 item (0.8% of the 118 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Lazard funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| The Toro Company | 2026-03-17 | Ratification of the selection of KPMG LLP as our independent registered public accounting firm for our fiscal year ending October 31, 2026. | Against | FOR — 4 of 4 Lazard funds | Against | Passed (calculated), 96.7% support |
Download all 1 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 88.6% of this fund’s 3,214 such votes could be given a sector; the other 365 (11.4%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Consumer Discretionary | 627 | 9 | 1.4% |
| Finance | 541 | 2 | 0.4% |
| Industrials | 454 | 6 | 1.3% |
| Technology | 364 | 5 | 1.4% |
| Real Estate | 294 | 0 | 0.0% |
| Health Care | 255 | 2 | 0.8% |
| Energy | 81 | 0 | 0.0% |
| Consumer Staples | 78 | 3 | 3.8% |
| Utilities | 60 | 1 | 1.7% |
| Miscellaneous | 58 | 0 | 0.0% |
| Basic Materials | 21 | 0 | 0.0% |
| Telecommunications | 16 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 2,266 | 2 |
| Say-on-Pay | 330 | 2 |
| Audit-related | 329 | 0 |
| Compensation | 135 | 0 |
| Corporate Governance | 98 | 17 |
| Capital Structure | 38 | 0 |
| Extraordinary Transactions | 36 | 0 |
| Shareholder Rights and Defenses | 6 | 1 |
| Diversity, Equity, and Inclusion | 2 | 2 |
| Environment or Climate | 2 | 2 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Coherent Corp. | November 13, 2025 | $556,706 | 7 | 0 |
| Onto Innovation Inc. | May 20, 2026 | $543,658 | 9 | 0 |
| Viavi Solutions Inc. | November 12, 2025 | $507,113 | 13 | 0 |
| Clover Health Investments, Corp. | June 10, 2026 | $499,539 | 5 | 0 |
| OPENLANE, Inc. | June 5, 2026 | $462,451 | 10 | 0 |
| Interface, Inc. | May 19, 2026 | $440,478 | 12 | 0 |
| Neurocrine Biosciences, Inc. | May 27, 2026 | $393,272 | 6 | 0 |
| Diodes Incorporated | May 11, 2026 | $385,327 | 9 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 8, 2026 | The Timken Company | Consideration of a shareholder proposal asking our Board of Directors to take the steps necessary to amend the appropriate Company governing documents to give the owners of a combined 10% of our outstanding common stock the power to call a special shareholder meeting or the owners of the lowest percentage of shareholders, as governed by state law, the power to call a special shareholder meeting. Shareholder proposal | For | Against |
| June 1, 2026 | DocuSign, Inc. | A stockholder proposal to report on the risks of non-fiduciary executive compensation metrics, if properly presented at the meeting Shareholder proposal | Against | For |
| May 12, 2026 | Arrow Electronics, Inc. | Shareholder proposal to provide shareholders with the ability to call a special shareholder meeting at a 10% ownership threshold. Shareholder proposal | For | Against |
| June 15, 2026 | HubSpot, Inc. | A stockholder proposal to change the Company's Sixth Amended and Restated Bylaws to allow 10% holders of the Company's stock the ability to call a special meeting; and Shareholder proposal | For | Against |
| May 20, 2026 | Universal Health Services, Inc. | Stockholder proposal to report votes based on UHS shareholder money at risk, if properly presented at the meeting. Shareholder proposal | For | Against |
| May 20, 2026 | Universal Health Services, Inc. | Stockholder proposal to adopt a policy requiring Universal Health Services, Inc. to publicly disclose its workforce diversity, if properly presented at the meeting. Shareholder proposal | Against | For |
| April 28, 2026 | AutoNation, Inc. | Adoption of stockholder proposal regarding independent board chairman. Shareholder proposal | Against | For |
| April 28, 2026 | AutoNation, Inc. | Adoption of stockholder proposal regarding GHG report. Shareholder proposal | Against | For |
| May 1, 2026 | Ryder System, Inc. | To vote, on an advisory basis, on a shareholder proposal regarding an independent board chair. Shareholder proposal | Against | For |
| April 23, 2026 | AGCO Corporation | Stockholder proposal regarding giving stockholders an ability to call for a special stockholder meeting, if properly presented at the meeting. Shareholder proposal | For | Against |
| March 9, 2026 | Sanmina Corporation | To consider and vote upon the stockholder proposal entitled "Independent Board Chairman," requesting that the Board of Directors adopt a policy and amend governing documents as necessary in order that two separate people hold the office of the Chairman and the office of the CEO. Shareholder proposal | Against | For |
| April 21, 2026 | Bio-Rad Laboratories, Inc. | Stockholder proposal regarding dual class capital structure. Shareholder proposal | Against | For |
Meetings with a proxy contest or competing nominees (2 in 2025-2026), and how the fund voted the items on its ballot.
3,247 ballot items at 364 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Lazard US Systematic Small Cap Equity ETF (SYZ) voted at 364 shareholder meetings of 356 companies, on 3,247 ballot items in all. Where management made a recommendation, the fund followed it on 99.1% of the items and voted against it 29 times. Its most frequent area of disagreement was corporate governance (17 of its votes against management). It voted on 27 shareholder proposals. It voted FOR the board's own proposals less often than Lazard's funds as a whole (85.2% against 89.1%). It voted differently from most Lazard funds on 1 item. 2 of its meetings were contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Lazard’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.